Journey Medical Corp
NASDAQ:DERM
Journey Medical Corp
NASDAQ:DERM
Price:
6.31
USD
1.77%
Market Closed
Market Cap:
$172m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Journey Medical Corp
NASDAQ:DERM
|
US |
|
G
|
Grindrod Ltd
JSE:GND
|
ZA |
|
CY4GATE SpA
MIL:CY4
|
IT |
|
Japfa Comfeed Indonesia Tbk PT
IDX:JPFA
|
ID |
|
Shopify Inc
NASDAQ:SHOP
|
CA |
|
Orkla ASA
OTC:ORKLY
|
NO |
|
Faraday Future Intelligent Electric Inc
NASDAQ:FFIE
|
US |
|
CureVac NV
NASDAQ:CVAC
|
DE |
|
Global Lithium Resources Ltd
ASX:GL1
|
AU |
|
Newton Golf Co
NASDAQ:NWTG
|
US |
|
Lifeline SPAC I Oyj
F:0CD
|
FI |
|
C
|
Calibre Mining Corp
OTC:CXBMF
|
CA |
|
M
|
Manulife Financial Corp
NYSE:MFC
|
CA |
|
M/I Homes Inc
NYSE:MHO
|
US |
|
Plant Health Care PLC
LSE:PHC
|
US |
Wall St Price Targets
DERM Price Targets Summary
Journey Medical Corp
Journey Medical Corp
Wall Street analysts forecast DERM stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for DERM is 13.77 USD with a low forecast of 12.12 USD and a high forecast of 16.8 USD.
Lowest Forecast
Price Target
12.12
USD
92% Upside
Average Forecast
Price Target
13.77
USD
118% Upside
Highest Forecast
Price Target
16.8
USD
166% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is DERM's stock price target?
Price Target
13.77
USD
13.77
USD
According to Wall Street analysts, the average 1-year price target for DERM is 13.77 USD with a low forecast of 12.12 USD and a high forecast of 16.8 USD.
What is the Revenue forecast for Journey Medical Corp?
Projected CAGR
48%
48%
Over the last 5 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 3 years is 48%.
